Lin En, Song Miaomiao, Wang Bo, Shi Xiaojing, Zhao Jiali, Fu Lidan, Bai Zirui, Zou Baojia, Zeng Guifang, Zhuo Wenfeng, Li Peiping, Cai Chaonong, Cheng Zhen, Hu Zhenhua, Li Jian
Department of Hepatobiliary Surgery and Liver Transplantation Center, The Fifth Affiliated Hospital of Sun Yat-Sen University, 52 Mei Hua East Road, Zhuhai, 519000, China.
CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, 95 Zhongguancun East Road, Beijing, 100190, China.
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2157-2170. doi: 10.1007/s00259-025-07093-6. Epub 2025 Jan 21.
Cancer-associated fibroblasts (CAFs) are the primary stromal component of the tumor microenvironment in hepatocellular carcinoma (HCC), affecting tumor progression and post-resection recurrence. Fibroblast activation protein (FAP) is a key biomarker of CAFs. However, there is limited evidence on using FAP as a target in near-infrared (NIR) fluorescence imaging for HCC. Thus, this study aims to develop a novel NIR fluorescent imaging strategy targeting FAP CAFs in HCC.
The ICG-FAP-TATA probe was synthesized by conjugating a novel cyclization anti-FAP peptide with an indocyanine green derivative (ICG-NH) as fluorophore, capable for NIR window I (NIR-I, 700-900 nm) and II (NIR-II, 1000-1700 nm) imaging. Its efficacy in lesion localization and other potential applications was evaluated.
In vivo imaging of subcutaneous HCC models revealed that ICG-FAP-TATA specifically targeted FAP CAFs in the stroma and detected differences in CAFs loading within lesions. The fluorescence intensity/tumor-to-background ratio (TBR) positively correlated with FAP expression (R > 0.8, p < 0.05). Ex vivo incubation of tumor tissues with ICG-FAP-TATA provided stable fluorescence imaging of tumors in subcutaneous and orthotopic HCC models, including different cell line co-culture systems (LM3-luc, MHCC97H-luc, HepG2-luc + LX2), and various liver backgrounds (healthy/fibrotic) (n = 5 per group). TBR of the tumor mice models was higher for NIR-II than NIR-I imaging (3.89 ± 1.27 vs. 2.64 ± 0.64, p < 0.05). Moreover, NIR-I/II imaging of fresh tissues from seven patients with HCC undergoing surgery incubated with ICG-FAP-TATA visually provided the spatial distribution heterogeneity of CAFs. The targeted fluorescence was relatively enriched more in the blood flow direction and at the tumor edge, both of which were associated with tumor metastasis (all p < 0.05).
This study presents a rapid and effective method for detecting HCC lesions, locating FAP CAFs, and visualizing high-risk areas for tumor metastasis at the macroscopic level. It offers a new promising approach with translational potential for imaging HCC.
癌症相关成纤维细胞(CAFs)是肝细胞癌(HCC)肿瘤微环境的主要基质成分,影响肿瘤进展和切除术后复发。成纤维细胞活化蛋白(FAP)是CAFs的关键生物标志物。然而,关于将FAP用作HCC近红外(NIR)荧光成像靶点的证据有限。因此,本研究旨在开发一种针对HCC中FAP CAFs的新型NIR荧光成像策略。
通过将一种新型环化抗FAP肽与作为荧光团的吲哚菁绿衍生物(ICG-NH)偶联,合成ICG-FAP-TATA探针,能够用于近红外窗口I(NIR-I,700-900nm)和II(NIR-II,1000-1700nm)成像。评估其在病变定位和其他潜在应用中的功效。
皮下HCC模型的体内成像显示,ICG-FAP-TATA特异性靶向基质中的FAP CAFs,并检测病变内CAFs负载的差异。荧光强度/肿瘤与背景比值(TBR)与FAP表达呈正相关(R>0.8,p<0.05)。用ICG-FAP-TATA对肿瘤组织进行离体孵育,在皮下和原位HCC模型中提供了稳定的肿瘤荧光成像,包括不同细胞系共培养系统(LM3-luc、MHCC97H-luc、HepG2-luc+LX2)和各种肝脏背景(健康/纤维化)(每组n=5)。肿瘤小鼠模型的NIR-II成像TBR高于NIR-I成像(3.89±1.27对2.64±0.64,p<0.05)。此外,用ICG-FAP-TATA孵育的7例接受手术的HCC患者新鲜组织的NIR-I/II成像在视觉上提供了CAFs的空间分布异质性。靶向荧光在血流方向和肿瘤边缘相对更富集,这两者均与肿瘤转移相关(所有p<0.05)。
本研究提出了一种快速有效的方法,用于检测HCC病变、定位FAP CAFs并在宏观水平可视化肿瘤转移的高危区域。它为HCC成像提供了一种具有转化潜力的新的有前景的方法。